Global Liquid Biopsy For Cancer Diagnostics Supply, Demand and Key Producers, 2023-2029
The global Liquid Biopsy For Cancer Diagnostics market size is expected to reach $ 8129.3 million by 2029, rising at a market growth of 11.9% CAGR during the forecast period (2023-2029).
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
This report studies the global Liquid Biopsy For Cancer Diagnostics demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Liquid Biopsy For Cancer Diagnostics, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Liquid Biopsy For Cancer Diagnostics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Liquid Biopsy For Cancer Diagnostics total market, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Liquid Biopsy For Cancer Diagnostics total market, key domestic companies and share, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics revenue by player and market share 2018-2023, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Type, CAGR, 2018-2029, (USD Million)
Global Liquid Biopsy For Cancer Diagnostics total market by Application, CAGR, 2018-2029, (USD Million).
This reports profiles major players in the global Liquid Biopsy For Cancer Diagnostics market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include F. Hoffman La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., The Menarini Group, Bio-Rad Laboratories Inc., QIAGEN Inc., Exact Sciences Corporation and Bio-Techne Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Liquid Biopsy For Cancer Diagnostics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Liquid Biopsy For Cancer Diagnostics Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation by Type
Blood Test
Urine Test
Saliva Test
Global Liquid Biopsy For Cancer Diagnostics Market, Segmentation by Application
Hospital
Diagnostic Center
Others
Companies Profiled:
F. Hoffman La Roche Ltd.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Illumina Inc.
The Menarini Group
Bio-Rad Laboratories Inc.
QIAGEN Inc.
Exact Sciences Corporation
Bio-Techne Corporation
ArcherDX Inc.
Neogenomics Laboratories Inc.
Guardant Health Inc.
Myriad Genetics Inc.
Foundation Medicine Inc.
Amoy Diagnostics Co. Ltd.
Biocartis Group NV
Key Questions Answered
1. How big is the global Liquid Biopsy For Cancer Diagnostics market?
2. What is the demand of the global Liquid Biopsy For Cancer Diagnostics market?
3. What is the year over year growth of the global Liquid Biopsy For Cancer Diagnostics market?
4. What is the total value of the global Liquid Biopsy For Cancer Diagnostics market?
5. Who are the major players in the global Liquid Biopsy For Cancer Diagnostics market?